search
Back to results

The DECRA Trial: Early Decompressive Craniectomy in Patients With Severe Traumatic Brain Injury

Primary Purpose

Brain Injuries

Status
Completed
Phase
Phase 3
Locations
Australia
Study Type
Interventional
Intervention
Early decompressive craniectomy
Sponsored by
National Trauma Research Institute
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Brain Injuries focused on measuring Severe diffuse TBI refractory intracranial hypertension.

Eligibility Criteria

15 Years - 60 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age 15 - 60 years and within the first 72 hrs from time of injury Severe diffuse Traumatic Brain Injury defined as: GCS < 9 and CT scan* with any evidence of brain swelling CT brain scan (DII + some evidence of swelling or DIII or DIV) OR GCS >8 before intubation and DIII or DIV CT brain scan (basal cistern compression ± midline shift) ICP monitor in situ. EVD recommended. "Refractory ICP" despite best conventional management. Refractory ICP in this study will be defined as the spontaneous persistent increase in ICP despite optimal conventional ICU therapies (including intermittent EVD venting) of >20mm Hg for more than 15 mins (continuously or cumulative over one hour). Exclusion criteria: Intracranial haemorrhage > 3 cm diameter Intracranial mixed haemorrhagic contusion >5cm in long axis Previous craniectomy EDH/SDH/ or large contusion requiring evacuation EDH/SDH >0.5 cm thickness Spinal cord injury Penetrating brain injury Arrest at scene Unreactive pupils >4mm, and GCS=3 Neurosurgery contraindicated (eg: severe coagulopathy) No chance of survival after consideration of CT and clinical findings following Neurosurgical consultant assessment (eg hemispheric infarct after carotid dissection).

Sites / Locations

  • The Alfred Hospital

Outcomes

Primary Outcome Measures

Proportion (%) of favourable outcomes (GOSE 5-8)

Secondary Outcome Measures

Mean and maximum hourly intracranial pressure (ICP)
Favourable outcomes (GOSE)
Mean GOSE using ordinal logistic regression
Mortality
length of stay
Brain metabolites using microdialysis (The Alfred Hospital only)

Full Information

First Posted
September 7, 2005
Last Updated
September 8, 2020
Sponsor
National Trauma Research Institute
Collaborators
National Health and Medical Research Council, Australia, Victorian Trauma Foundation, ANZICS Foundation, Western Australian Institute for Medical Research
search

1. Study Identification

Unique Protocol Identification Number
NCT00155987
Brief Title
The DECRA Trial: Early Decompressive Craniectomy in Patients With Severe Traumatic Brain Injury
Official Title
Multi-centre Prospective Randomised Trial of Early Decompressive Craniectomy in Patients With Severe Traumatic Brain Injury
Study Type
Interventional

2. Study Status

Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
August 2003 (undefined)
Primary Completion Date
November 2010 (Actual)
Study Completion Date
December 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
National Trauma Research Institute
Collaborators
National Health and Medical Research Council, Australia, Victorian Trauma Foundation, ANZICS Foundation, Western Australian Institute for Medical Research

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a multi-centre randomised trial to evaluate the effect of early decompressive craniectomy on neurological function in patients with severe traumatic brain injury. The primary outcome is neurological function measured at 6 months post injury using the Glasgow Outcome Score. Neurological function is qualified as proportion of favourable outcomes (Glasgow Outcome Score Extended [GOSE] grades 5-8).
Detailed Description
Comparison After meeting the entry criteria, and the patient will be randomised to either early DC surgery (see below) or best current conventional management. Those randomised to surgery will have the operation done within 6 hours of randomisation. They will then return to the ICU and be managed thereafter in the same way as the conventional arm. Patients in the conventional arm will have all the usual therapies for increasing ICP optimised again. They then may have cooling to 35.0C or thiopentone bolus or thiopentone coma. These options are at the clinicians discretion. Late DC surgery in the control patients is discouraged however it may be done at the neurosurgeons discretion. These patients will be included in the intention to treat analysis. Surgical Technique The technique described by Polin will be used. The operation will comprise bi-frontal decompressive craniectomies with a single fronto-temporal bone flap extending across the midline. The temporalis muscles will be reflected inferiorly. Burr holes are located either side of the sagittal sinus at the posterior extent and bilaterally at the keyhole and at the root of the zygoma. This will create a large bifrontal craniectomy defect extending posteriorly to the coronal sutures. Bilateral large sub-temporal decompressions will be performed down to the skull base. The final bone cut is made along the supra-orbital ridges with an attempt to preserve the frontal sinus. Burr holes will be placed either side of the sagittal sinus inferiorly and the bone will be lifted out. The dura will be opened in one of two alternative ways: The dura is opened with a cruciate incision bilaterally. OR A large L shaped incision with the lower corner of the L facing laterally. The advantage to this method is that the cerebral veins are not disturbed medially by this incision. The dural opening should be covered with a dural or facial patch, so that the brain does not adhere to the scalp. Water tight dural closure is not necessarily aimed for. For patients receiving EVD monitoring, an ICP monitor with ventricular catheter (± optional PO2 and temperature monitor) may be placed prior to closure. Some patients will have been randomised to parenchymal catheter only. These patients will not have an EVD inserted. The bone flap is replaced once bone swelling has resolved and the patient has improved and left the intensive care unit (6-12 weeks). The bone flap is stored at minus 20o-70oC until reinsertion or it may be implanted in the subcutaneous tissue of the abdominal wall as an alternative.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Brain Injuries
Keywords
Severe diffuse TBI refractory intracranial hypertension.

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
155 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
Early decompressive craniectomy
Intervention Description
Large bifrontotemporal decompressive craniectomy
Primary Outcome Measure Information:
Title
Proportion (%) of favourable outcomes (GOSE 5-8)
Time Frame
6 month post injury
Secondary Outcome Measure Information:
Title
Mean and maximum hourly intracranial pressure (ICP)
Time Frame
36hrs post randomisation
Title
Favourable outcomes (GOSE)
Time Frame
12 months post injury
Title
Mean GOSE using ordinal logistic regression
Time Frame
6 months and 12 months
Title
Mortality
Time Frame
hospital, 6 months, 12 months
Title
length of stay
Time Frame
ICU admisssion
Title
Brain metabolites using microdialysis (The Alfred Hospital only)
Time Frame
During monitoring phase

10. Eligibility

Sex
All
Minimum Age & Unit of Time
15 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 15 - 60 years and within the first 72 hrs from time of injury Severe diffuse Traumatic Brain Injury defined as: GCS < 9 and CT scan* with any evidence of brain swelling CT brain scan (DII + some evidence of swelling or DIII or DIV) OR GCS >8 before intubation and DIII or DIV CT brain scan (basal cistern compression ± midline shift) ICP monitor in situ. EVD recommended. "Refractory ICP" despite best conventional management. Refractory ICP in this study will be defined as the spontaneous persistent increase in ICP despite optimal conventional ICU therapies (including intermittent EVD venting) of >20mm Hg for more than 15 mins (continuously or cumulative over one hour). Exclusion criteria: Intracranial haemorrhage > 3 cm diameter Intracranial mixed haemorrhagic contusion >5cm in long axis Previous craniectomy EDH/SDH/ or large contusion requiring evacuation EDH/SDH >0.5 cm thickness Spinal cord injury Penetrating brain injury Arrest at scene Unreactive pupils >4mm, and GCS=3 Neurosurgery contraindicated (eg: severe coagulopathy) No chance of survival after consideration of CT and clinical findings following Neurosurgical consultant assessment (eg hemispheric infarct after carotid dissection).
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
D. J. Cooper
Organizational Affiliation
The Alfred Hospital & National Trauma Research Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Alfred Hospital
City
Melbourne
State/Province
Victoria
ZIP/Postal Code
3004
Country
Australia

12. IPD Sharing Statement

Learn more about this trial

The DECRA Trial: Early Decompressive Craniectomy in Patients With Severe Traumatic Brain Injury

We'll reach out to this number within 24 hrs